RetinalGenix (RTGN) 10-Q 2024 Q2 Quarterly report

Exhibit 32.2

Statement of Principal Executive Officer and Principal Financial Officer

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of RetinalGenix Technologies Inc. (the “Registrant”), hereby certifies, to such officer’s knowledge, that:

1.	The accompanying quarterly report on Form 10-Q for the period ended June 30, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Date: August 19, 2024	By:	/s/ Jerry Katzman
		Jerry Katzman
		Interim Chief Financial Officer
		(Principal Financial and Accounting Officer)